Literature DB >> 10026271

UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme.

J E Jackman1, C R Raetz, C A Fierke.   

Abstract

The enzyme UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc deacetylase (LpxC) catalyzes the committed step in the biosynthesis of lipid A and is therefore a potential antibiotic target. Inhibition of this enzyme by hydroxamate compounds [Onishi, H. R.; Pelak, B. A.; Gerckens, L. S.; Silver, L. L.; Kahan, F. M.; Chen, M. H.; Patchett, A. A.; Stachula, S. S.; Anderson, M. S.; Raetz, C. R. H. (1996) Science 274, 980-982] suggested the presence of a metal ion cofactor. We have investigated the substrate specificity and metal dependence of the deacetylase using spectroscopic and kinetic analyses. Comparison of the steady-state kinetic parameters for the physiological substrate UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and an alternative substrate, UDP-GlcNAc, demonstrates that the ester-linked R-3-hydroxymyristoyl chain increases kcat/KM (5 x 10(6))-fold. Metal-chelating reagents, such as dipicolinic acid (DPA) and ethylenediaminetetraacetic acid, completely inhibit LpxC activity, implicating an essential metal ion. Plasma emission spectroscopy and colorimetric assays directly demonstrate that purified LpxC contains bound Zn2+. This Zn2+ can be removed by incubation with DPA, causing a decrease in the LpxC activity that can be restored by subsequent addition of Zn2+. However, high concentrations of Zn2+ also inhibit LpxC. Addition of Co2+, Ni2+, or Mn2+ to apo-LpxC also activates the enzyme to varying degrees while no additional activity is observed upon the addition of Cd2+, Ca2+, Mg2+, or Cu2+. This is consistent with the profile of metals that substitute for catalytic zinc ions in metalloproteinases. Co2+ ions stimulate LpxC activity maximally at a stoichiometry of 1:1. These data demonstrate that E. coli LpxC is a metalloenzyme that requires bound Zn2+ for optimal activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026271     DOI: 10.1021/bi982339s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.

Authors:  Douglas A Whittington; Kristin M Rusche; Hyunshun Shin; Carol A Fierke; David W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-20       Impact factor: 11.205

3.  Structure of the LpxC deacetylase with a bound substrate-analog inhibitor.

Authors:  Brian E Coggins; Xuechen Li; Amanda L McClerren; Ole Hindsgaul; Christian R H Raetz; Pei Zhou
Journal:  Nat Struct Biol       Date:  2003-08

4.  4D-LQTA-QSAR and docking study on potent Gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling.

Authors:  Jahan B Ghasemi; Reihaneh Safavi-Sohi; Euzébio G Barbosa
Journal:  Mol Divers       Date:  2011-11-30       Impact factor: 2.943

5.  Antimicrobial activity of CHIR-090, an inhibitor of lipopolysaccharide biosynthesis, against the Burkholderia cepacia complex.

Authors:  Karin Bodewits; Christian R H Raetz; John R Govan; Dominic J Campopiano
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

6.  Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090 .

Authors:  Kathryn E Cole; Samuel G Gattis; Heather D Angell; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2010-12-20       Impact factor: 3.162

7.  Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase.

Authors:  Heather A Gennadios; Douglas A Whittington; Xuechen Li; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2006-07-04       Impact factor: 3.162

8.  Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.

Authors:  Khisimuzi E Mdluli; Pamela R Witte; Toni Kline; Adam W Barb; Alice L Erwin; Bryce E Mansfield; Amanda L McClerren; Michael C Pirrung; L Nathan Tumey; Paul Warrener; Christian R H Raetz; C Kendall Stover
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

9.  Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.

Authors:  Igor Mochalkin; John D Knafels; Sandra Lightle
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

Review 10.  Structure, inhibition, and regulation of essential lipid A enzymes.

Authors:  Pei Zhou; Jinshi Zhao
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-12-09       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.